REG - Oxford Biomedica PLC - Interim Results <Origin Href="QuoteRef">OXB.L</Origin> - Part 2

Oxford BioMedicaAnnouncement

27/08/2015 07:02

- Part 2: For the preceding part double click  ID:nRSa2197Xa 

the principal risks and uncertainties for the remaining six
months of the financial year; and 
 
·      Material related party transactions in the first six months and any
material change in related-party transactions described in the last annual
report. 
 
By order of the Board 
 
John Dawson 
 
Chief Executive Officer 
 
26 August 2015 
 
Shareholder Information 
 
 DirectorsNick Rodgers(Non-executive Chairman) John Dawson(Chief Executive Officer) Tim Watts(Chief Financial Officer and Company Secretary) Peter Nolan(Chief Business Officer) Paul Blake(Chief Development Officer) Andrew Heath(Deputy Chairman and Senior Independent Director) Dan Soland(Non-executive Director) Martin Diggle(Non-executive Director) Financial AdviserWG Partners85 Gresham StreetLondon EC2V 7NQ RegistrarsCapita Asset ServicesThe Registry34 Beckenham RoadBeckenhamKent BR3 4TU Financial and Corporate CommunicationsConsilium Strategic Communications41 LothburyLondon EC2R 7HG Registered    
                                                                                                                                                                                                                                                                                                                                                             AuditorsPricewaterhouseCoopers LLPOne Reading Central23 Forbury RoadReadingRG1 3JH SolicitorsCovington & Burling LLP265 StrandLondon WC2R 1BH                                                                                                                   
 Registered Office Oxford BioMedica plcWindrush CourtTransport WayOxford OX4 6LTUnited Kingdom  Tel: +44 (0) 1865 783 000Fax:+44 (0) 1865 783 001 enquiries@oxfordbiomedica.co.ukwww.oxfordbiomedica.co.uk                                                                                                                                                                                                                                                                                                                                                                                                                   
 
 
This information is provided by RNS
The company news service from the London Stock Exchange